EUVIMEDEUVIMED entdecken
Crossref

The RELA-FTH1 axis in senescent cancer-associated fibroblasts creates a stromal iron sink that drives ferroptosis resistance and therapy failure across solid malignant tumors

Hexin Ma, Xinran Zhao, Zhen Zhang, Zhihui Li, Xinhua Pan, Haoming Zhao, Mengxuan Du, Qingqing Wan, Xin Zou, Jinye Fu, Hongyu Zhao, Xin Zhang und 1 weitere

Drug Resistance Updates · 2026-09 · 88 · 101415

DOI: 10.1016/j.drup.2026.101415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2026-09. Verfasst von Hexin Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; Coll…. Hauptthemen laut MEDLINE: Ferroptosis, Drug Resistance, Neoplasm, Cancer-Associated Fibroblasts, Transcription Factor RelA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Innovative Research Team of High-level Local Universities in Shanghai, National Natural Science Foundation of China, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Therapy resistance remains the foremost barrier to improving outcomes in solid malignancies. While tumor-cell-intrinsic resistance mechanisms have been extensively studied, the contribution of the tumor microenvironment (TME) to treatment failure is poorly understood. Cellular senescence accumulates across diverse solid tumor types and reshapes the stromal landscape, yet which population dominates this senescent compartment and how senescent cancer-associated fibroblasts (senCAFs) drive resistance remain unresolved. In particular, whether senescent fibroblasts can suppress ferroptosis in neighboring tumor cells-and thereby promote drug resistance-through metabolic reprogramming of iron homeostasis has not been mechanistically dissected. METHODS: We integrated six single-cell RNA sequencing datasets (431,513 cells) to map the senescent landscape of the TME. A 24-gene prognostic senescent fibroblast signature was constructed using LASSO/Cox regression and validated in independent TCGA cohorts. Transcription factor prediction and protein-DNA molecular docking identified upstream regulators. Functional studies employed conditioned medium assays, transwell co-culture systems with ferroptosis induction and chemosensitivity testing, FerroOrange-based intracellular Fe²⁺ quantification, genetic perturbation (shRNA/siRNA), pharmacological NF-κB inhibition, and subcutaneous xenograft models. Spatial transcriptomics validated findings in cancer tissues. Pan-cancer analyses across 31 solid malignant tumor types were performed using GEPIA 2 to assess cross-cancer generalizability. RESULTS: SenCAFs constituted the predominant senescent compartment in the TME, significantly promoting tumor cell proliferation, migration, invasion, and in vivo tumor growth. Multi-omics screening prioritized ferritin heavy chain 1 (FTH1) as the critical effector. Mechanistically, senCAFs upregulated FTH1 to create a stromal iron sink, sequestering microenvironmental Fe2 +, shielding tumor cells from ferroptosis. Disruption of this stromal iron sink by FTH1 silencing not only restored ferroptosis sensitivity but also resensitized tumor cells to cisplatin-induced apoptosis. This iron sink was transcriptionally driven by RELA; targeting RELA abolished FTH1 expression and the senescence phenotype. Spatial transcriptomics validated the FTH1-senCAF-NF-κB axis in situ. Critically, pan-solid tumor analysis also confirmed that upregulation of the RELA-FTH1 axis was associated with poor prognosis and positively correlated with ferroptosis resistance and multiple drug resistance pathways across 31 solid malignancies. CONCLUSIONS: SenCAFs drive therapy resistance by establishing a RELA-FTH1-dependent stromal iron sink. This axis serves as a pan-cancer prognostic and drug resistance biomarker and represents a druggable stromal vulnerability, suggesting that its disruption may resensitize resistant solid malignant tumors to ferroptosis and chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisDrug Resistance, NeoplasmCancer-Associated FibroblastsTranscription Factor RelAIronNeoplasmsFerritinsHumansCellular SenescenceTumor MicroenvironmentAnimalsGene Expression Regulation, NeoplasticCell Line, TumorMiceAntineoplastic Agents

Stichwörter der Autor:innen

FTH1Ferroptosis resistanceRELASenescent cancer-associated fibroblastsStromal iron sinkTherapy resistance

Substanzen

Transcription Factor RelAIronRELA protein, humanFerritinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for…
  • National Center for Translational Medicine (Shanghai) Linyi Branch & Institute of Translational Medicine Linyi University; School of Medicine, Linyi University, Linyi, Shandong, China.
  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: zhongyu93@163.com.
  • Digital Diagnosis and Treatment Innovation Center for Cancer, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address: xz404@sjtu.edu.cn.

Förderung

  • Innovative Research Team of High-level Local Universities in Shanghai
  • National Natural Science Foundation of China
  • Shanghai Jiao Tong University
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Ma, H., Zhao, X., Zhang, Z., Li, Z., Pan, X., Zhao, H., Du, M., Wan, Q., Zou, X., Fu, J., Zhao, H., Zhang, X., & Chen, W. T. (2026). The RELA-FTH1 axis in senescent cancer-associated fibroblasts creates a stromal iron sink that drives ferroptosis resistance and therapy failure across solid malignant tumors. Drug Resistance Updates, 88, 101415. https://doi.org/10.1016/j.drup.2026.101415

Vancouver

Ma H, Zhao X, Zhang Z, Li Z, Pan X, Zhao H, et al. The RELA-FTH1 axis in senescent cancer-associated fibroblasts creates a stromal iron sink that drives ferroptosis resistance and therapy failure across solid malignant tumors. Drug Resistance Updates. 2026;88:101415. doi:10.1016/j.drup.2026.101415

BibTeX
@article{Ma2026,
  author = {Ma, Hexin and Zhao, Xinran and Zhang, Zhen and Li, Zhihui and Pan, Xinhua and Zhao, Haoming and Du, Mengxuan and Wan, Qingqing and Zou, Xin and Fu, Jinye and Zhao, Hongyu and Zhang, Xin and Chen, Wan-Tao},
  title = {The RELA-FTH1 axis in senescent cancer-associated fibroblasts creates a stromal iron sink that drives ferroptosis resistance and therapy failure across solid malignant tumors},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {88},
  pages = {101415},
  doi = {10.1016/j.drup.2026.101415}
}
Kostenlos starten →